ALMS
ALUMIS INC.
NASDAQ · Healthcare · Biotechnology · US
$7.77
−0.64%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 189.76x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.22x
- Price / sales
- 135.94x
- Price / cash flow
- -2.86x
Enterprise value
- Enterprise value
- $539.8M
- EV / sales
- 72.97x
- EV / EBITDA
- -1.22x
- EV / EBIT
- -1.18x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026